| abstract |
A method for treating or preventing bronchoconstriction or nreversible pulmonary vasoconstriction in a mammal, which method nincludes causing the mammal to inhale a therapeutically-effective nconcentration of gaseous nitric oxide (1,10) or a ntherapeutically-effective amount of a nitric oxide-releasing ncompound (106), and an inhaler device (102) containing nitric noxide gas and/or a nitric oxide-releasing compound. |